Lexicon Pharmaceuticals
LXRX
#6259
Rank
โ‚น101.75 B
Marketcap
โ‚น228.70
Share price
-2.83%
Change (1 day)
150.84%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Net assets

Net assets on the balance sheet as of March 2026 : โ‚น19.33 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has โ‚น19.33 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lexicon Pharmaceuticals - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$โ‚น9.65 B-22.9%
2024-12-31$โ‚น12.52 B61.53%
2023-12-31$โ‚น7.75 B-20.02%
2022-12-31$โ‚น9.69 B14.63%
2021-12-31$โ‚น8.45 B-26.07%
2020-12-31$โ‚น11.43 B36.95%
2019-12-31$โ‚น8.35 B-552.29%
2018-12-31$-โ‚น1.85 Billion-142.36%
2017-12-31$โ‚น4.35 B-59.25%
2016-12-31$โ‚น10.69 B-43.69%
2015-12-31$โ‚น18.99 B5.53%
2014-12-31$โ‚น18.00 B71.23%
2013-12-31$โ‚น10.51 B-28%
2012-12-31$โ‚น14.60 B-7.24%
2011-12-31$โ‚น15.74 B42.21%
2010-12-31$โ‚น11.06 B45.91%
2009-12-31$โ‚น7.58 B-19.4%
2008-12-31$โ‚น9.41 B-16.31%
2007-12-31$โ‚น11.24 B196.99%
2006-12-31$โ‚น3.78 B-1.92%
2005-12-31$โ‚น3.86 B-26.68%
2004-12-31$โ‚น5.26 B-30.42%
2003-12-31$โ‚น7.56 B-7.12%
2002-12-31$โ‚น8.14 B-22.67%
2001-12-31$โ‚น10.53 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น4.960 T 25,564.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น254.99 B 1,219.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น2.994 T 15,390.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น21.83 Billion-212.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น95.03 B 391.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น29.35 Billion-251.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น15.63 Billion-180.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น591.95 B 2,962.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚น0.65 B-96.62%๐Ÿ‡บ๐Ÿ‡ธ USA